85 related articles for article (PubMed ID: 20236783)
1. High-throughput screening strategy for photogenotoxic potential of pharmaceutical substances using fluorescent intercalating dye.
Seto Y; Ochi M; Onoue S; Yamada S
J Pharm Biomed Anal; 2010 Sep; 52(5):781-6. PubMed ID: 20236783
[TBL] [Abstract][Full Text] [Related]
2. In vitro/in vivo phototoxic risk assessments of griseofulvin based on photobiochemical and pharmacokinetic behaviors.
Seto Y; Onoue S; Yamada S
Eur J Pharm Sci; 2009 Sep; 38(2):104-11. PubMed ID: 19576281
[TBL] [Abstract][Full Text] [Related]
3. Reactive oxygen species assay-based risk assessment of drug-induced phototoxicity: classification criteria and application to drug candidates.
Onoue S; Kawamura K; Igarashi N; Zhou Y; Fujikawa M; Yamada H; Tsuda Y; Seto Y; Yamada S
J Pharm Biomed Anal; 2008 Aug; 47(4-5):967-72. PubMed ID: 18455898
[TBL] [Abstract][Full Text] [Related]
4. Novel methodology for predicting photogenotoxic risk of pharmaceutical substances based on reactive oxygen species (ROS) and DNA-binding assay.
Onoue S; Seto Y; Oishi A; Yamada S
J Pharm Sci; 2009 Oct; 98(10):3647-58. PubMed ID: 19130470
[TBL] [Abstract][Full Text] [Related]
5. High-throughput reactive oxygen species (ROS) assay: an enabling technology for screening the phototoxic potential of pharmaceutical substances.
Onoue S; Igarashi N; Yamada S; Tsuda Y
J Pharm Biomed Anal; 2008 Jan; 46(1):187-93. PubMed ID: 17935922
[TBL] [Abstract][Full Text] [Related]
6. Capillary electrophoretic studies on the photogenotoxic potential of pharmaceutical substances.
Onoue S; Igarashi N; Kitagawa F; Otsuka K; Tsuda Y
J Chromatogr A; 2008 Apr; 1188(1):50-6. PubMed ID: 17980379
[TBL] [Abstract][Full Text] [Related]
7. In vitro phototoxicity of dihydropyridine derivatives: a photochemical and photobiological study.
Onoue S; Igarashi N; Yamauchi Y; Murase N; Zhou Y; Kojima T; Yamada S; Tsuda Y
Eur J Pharm Sci; 2008 Mar; 33(3):262-70. PubMed ID: 18207709
[TBL] [Abstract][Full Text] [Related]
8. In vitro photogenotoxic activity of clinafloxacin: a paradigm predicting photocarcinogenicity.
Bulera SJ; Theiss JC; Festerling TA; de la Iglesia FA
Toxicol Appl Pharmacol; 1999 May; 156(3):222-30. PubMed ID: 10222314
[TBL] [Abstract][Full Text] [Related]
9. High-throughput screening system for identifying phototoxic potential of drug candidates based on derivatives of reactive oxygen metabolites.
Onoue S; Ochi M; Gandy G; Seto Y; Igarashi N; Yamauchi Y; Yamada S
Pharm Res; 2010 Aug; 27(8):1610-9. PubMed ID: 20422261
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of chemical photoreactivity and the relationship to photogenotoxicity.
Lynch AM; Smith MD; Lane AS; Robinson SA; Kleinman MH; Kennedy-Gabb S; Wilcox P; Rees RW
Regul Toxicol Pharmacol; 2010 Nov; 58(2):219-23. PubMed ID: 19914326
[TBL] [Abstract][Full Text] [Related]
11. The photo comet assay--a fast screening assay for the determination of photogenotoxicity in vitro.
Struwe M; Greulich KO; Suter W; Plappert-Helbig U
Mutat Res; 2007 Aug; 632(1-2):44-57. PubMed ID: 17572134
[TBL] [Abstract][Full Text] [Related]
12. In vitro photobiochemical characterization of sulfobutylether-β-cyclodextrin formulation of bufexamac.
Seto Y; Ochi M; Igarashi N; Inoue R; Oishi A; Toida T; Yamada S; Onoue S
J Pharm Biomed Anal; 2011 Jun; 55(3):591-6. PubMed ID: 21429689
[TBL] [Abstract][Full Text] [Related]
13. Predicting phospholipidosis: a fluorescence noncell based in vitro assay for the determination of drug-phospholipid complex formation in early drug discovery.
Zhou L; Geraci G; Hess S; Yang L; Wang J; Argikar U
Anal Chem; 2011 Sep; 83(18):6980-7. PubMed ID: 21790130
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Vitotox and RadarScreen assays for the rapid assessment of genotoxicity in the early research phase of drug development.
Westerink WM; Stevenson JC; Lauwers A; Griffioen G; Horbach GJ; Schoonen WG
Mutat Res; 2009 May; 676(1-2):113-30. PubMed ID: 19393335
[TBL] [Abstract][Full Text] [Related]
15. A novel and simple method of screening compounds for interaction with DNA: A validation study.
Garas A; Webb E; Pillay V; MacPhee D; Denny W; Zeller H; Cotton R
Mutat Res; 2009 Aug; 678(1):20-9. PubMed ID: 19559098
[TBL] [Abstract][Full Text] [Related]
16. Validation of a high-throughput in vitro alkaline elution/rat hepatocyte assay for DNA damage.
Gealy R; Wright-Bourque JL; Kraynak AR; McKelvey TW; Barnum JE; Storer RD
Mutat Res; 2007 Apr; 629(1):49-63. PubMed ID: 17306613
[TBL] [Abstract][Full Text] [Related]
17. In vitro to in vivo concordance of a high throughput assay of bone marrow toxicity across a diverse set of drug candidates.
Olaharski AJ; Uppal H; Cooper M; Platz S; Zabka TS; Kolaja KL
Toxicol Lett; 2009 Jul; 188(2):98-103. PubMed ID: 19446241
[TBL] [Abstract][Full Text] [Related]
18. Combined use of in vitro phototoxic assessments and cassette dosing pharmacokinetic study for phototoxicity characterization of fluoroquinolones.
Seto Y; Inoue R; Ochi M; Gandy G; Yamada S; Onoue S
AAPS J; 2011 Sep; 13(3):482-92. PubMed ID: 21739333
[TBL] [Abstract][Full Text] [Related]
19. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
[TBL] [Abstract][Full Text] [Related]
20. The polarization of fluorescence of DNA stains depends on the incorporation density of the dye molecules.
Uy JL; Asbury CL; Petersen TW; van den Engh G
Cytometry A; 2004 Sep; 61(1):18-25. PubMed ID: 15351985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
